2014Wiley StatsRef: Statistics Reference OnlineRequires access

Double‐Dummy

Kenneth F. Schulz

Open publisher page 0 citations

Abstract

Abstract Blinding embodies a rich history spanning several centuries. Double‐blinding usually reduces differential assessment of outcomes (information bias), but can also improve compliance and retention of trial participants while reducing biased supplemental care or treatment (sometimes called co‐intervention). With an active treatment control group, different options to double‐blinding present production obstacles, compliance impediments, and unblinding opportunities. To double‐blind in this situation, double‐dummy blinding nearly always becomes indispensable.

About this research paper

What this paper is about

Abstract Blinding embodies a rich history spanning several centuries. Double‐blinding usually reduces differential assessment of outcomes (information bias), but can also improve compliance and retention of trial participants while reducing biased supplemental care or treatment (sometimes called co‐intervention). With an active treatment control group, different options to double‐blinding present production obstacles, compliance impediments, and unblinding opportunities. To double‐blind in this situation, double‐dummy blinding nearly always becomes indispensable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Blinding embodies a rich history spanning several centuries. Double‐blinding usually reduces differential assessment of outcomes (information bias), but can also improve compliance and retention of trial participants while reducing biased supplemental care or treatment (sometimes called co‐intervention). With an active treatment control group, different options to double‐blinding present production obstacles, compliance impediments, and unblinding opportunities. To double‐blind in this situation, double‐dummy blinding nearly always becomes indispensable.

Key concepts: Blinding, Double blind, Control (management), Medicine, Psychology, Computer science, Clinical trial, Alternative medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Double‐Dummy — Research Paper | ScholarLens